In the realm of pharmaceutical synthesis, understanding the intricate details of chemical intermediates is key to innovation and successful production. 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine, identified by its CAS number 230615-69-7, stands out as a crucial component in the manufacturing of Varenicline, a leading medication in smoking cessation programs.

This compound is characterized by its complex fused ring system and the presence of a trifluoroacetyl group, which significantly influences its chemical behavior and its role in synthesis. The molecule features a benzazepine backbone, essential for achieving the desired biological activity of the final drug product. Typically appearing as a white to light yellow crystalline powder, its physical properties, such as melting point (83-88°C) and solubility, are critical for process chemists to optimize reaction conditions. Its molecular formula is C13H14F3N3O, with a molecular weight of 285.27 g/mol.

For pharmaceutical manufacturers, securing a reliable supply of this intermediate with high purity is paramount. We, as a specialized manufacturer and supplier, focus on delivering this compound with purity levels exceeding 98%. Our commitment to quality ensures that researchers and production teams can confidently integrate it into their synthesis pathways. Whether you are in the R&D phase or scaling up for commercial production, our ability to provide consistent quality and quantity makes us an ideal partner. Buying this pharmaceutical intermediate from us means investing in a stable supply chain and a product that meets stringent industry standards.

We encourage pharmaceutical companies to explore our offerings for 2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine-7,8-diamine. By leveraging our manufacturing expertise and dedication to quality, you can ensure the efficiency and success of your Varenicline production. Contact us to inquire about bulk orders, pricing, and technical specifications for this vital intermediate.